Lyell Immunopharma Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20,416.0% | 38,900.0% | 167,466.7% | 37,700.0% | – | 45,690.9% | – | 39,187.5% | – | 39,950.0% | 116,600.0% | – | – | |
| -20,316.0% | -38,800.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -116,500.0% | 100.0% | -8,537.0% | |
| 159,964.0% | 320,146.2% | 1,439,133.3% | 309,700.0% | 116,176.5% | 442,436.4% | 620,671.4% | 435,712.5% | 187,813.3% | 869,983.3% | 1,830,200.0% | 988,100.0% | 579,625.9% | |
| 62,028.0% | 101,284.6% | 449,800.0% | 94,276.9% | 34,614.7% | 132,018.2% | 200,657.1% | 122,325.0% | 71,246.7% | 176,933.3% | 477,750.0% | 239,400.0% | 149,755.6% | |
| 221,992.0% | 421,430.8% | 1,852,600.0% | 396,469.2% | 148,644.1% | 1,828,709.1% | 819,628.6% | 589,350.0% | 248,453.3% | 1,021,966.7% | 2,191,350.0% | 1,183,525.0% | 702,792.6% | |
| -242,308.0% | -460,230.8% | -1,852,500.0% | -396,369.2% | -148,544.1% | -1,828,609.1% | -819,528.6% | -589,250.0% | -248,353.3% | -1,021,866.7% | -2,307,850.0% | -1,183,425.0% | -711,329.6% | |
| -203,412.0% | -407,153.8% | -2,022,233.3% | -352,376.9% | -131,126.5% | -1,744,863.6% | -745,642.9% | -533,550.0% | -258,973.3% | -2,345,383.3% | -1,207,650.0% | -1,118,875.0% | -920,285.2% | |
| -26,432.0% | 38,563.0% | 166,024.1% | – | – | – | – | – | – | – | – | – | – | |
| -203,412.0% | -407,153.8% | -2,022,233.3% | -352,376.9% | -131,126.5% | -1,744,863.6% | -745,642.9% | -533,550.0% | -258,973.3% | -2,345,383.3% | -1,207,650.0% | -1,118,875.0% | -920,285.2% | |
| -182,996.0% | -368,253.8% | -1,854,766.7% | -314,676.9% | -117,361.8% | -524,000.0% | -696,485.7% | -532,025.0% | -241,866.7% | -2,305,433.3% | -1,091,050.0% | -1,063,325.0% | -885,037.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.